News
-
-
-
COMMUNIQUÉ DE PRESSE
aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
aap Implantate AG successfully closes financial year 2024 with positive developments, achieving sales growth and strengthening market position, especially in EMEA and LATAM regions -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements
aap Implantate AG reports Company EBITDA of EUR -0.85 million for fiscal year 2024, leading to the postponement of consolidated financial statements publication. Analysts review impact -
-
-
COMMUNIQUÉ DE PRESSE
aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region
aap Implantate AG reports stable business development in Q1 2025, with significant sales growth in the EMEA region and successful new product placements. The company anticipates further growth in Q2 -
